YU71195A - Prečišćeni proteini papilomavirusa - Google Patents

Prečišćeni proteini papilomavirusa

Info

Publication number
YU71195A
YU71195A YU71195A YU71195A YU71195A YU 71195 A YU71195 A YU 71195A YU 71195 A YU71195 A YU 71195A YU 71195 A YU71195 A YU 71195A YU 71195 A YU71195 A YU 71195A
Authority
YU
Yugoslavia
Prior art keywords
purified
papilloma virus
protein
virus proteins
yeast host
Prior art date
Application number
YU71195A
Other languages
English (en)
Inventor
Ernest D. Lehman
James C. Cook Iii
George A. Hugh
Kathryn J. Hofmann
Kathrin U. Jansen
Joseph G. Joyce
Henry Z. Markus
Loren D. Schultz
Original Assignee
Merck And Co.Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck And Co.Inc. filed Critical Merck And Co.Inc.
Publication of YU71195A publication Critical patent/YU71195A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Prečišćeni papilomavirus protein se dobija transformisanjem ćelije domaćina kvasca sa genom koji kodira bilo L1 ili L1 u kombinaciji sa L2 proteinom, kultivisanjem ćelija domaćina kvasca, i prečišćavanjem ekspresionisanog proteina koristeći najmanje jedan hromatografski stupanj. Prečišćeni protein je najmanje 70% čist.
YU71195A 1994-11-14 1995-11-14 Prečišćeni proteini papilomavirusa YU71195A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33936894A 1994-11-14 1994-11-14

Publications (1)

Publication Number Publication Date
YU71195A true YU71195A (sh) 1999-06-15

Family

ID=23328696

Family Applications (1)

Application Number Title Priority Date Filing Date
YU71195A YU71195A (sh) 1994-11-14 1995-11-14 Prečišćeni proteini papilomavirusa

Country Status (23)

Country Link
EP (1) EP0789767B1 (sh)
JP (1) JPH11500002A (sh)
KR (1) KR987000420A (sh)
CN (1) CN1173203A (sh)
AR (1) AR004464A1 (sh)
AT (1) ATE245192T1 (sh)
AU (1) AU708737B2 (sh)
BR (1) BR9510520A (sh)
CZ (1) CZ145297A3 (sh)
DE (1) DE69531308T2 (sh)
DK (1) DK0789767T3 (sh)
ES (1) ES2201129T3 (sh)
FI (1) FI972030A (sh)
HR (1) HRP950557A2 (sh)
HU (1) HUT77559A (sh)
MX (1) MX9703570A (sh)
NZ (1) NZ298224A (sh)
PT (1) PT789767E (sh)
RU (1) RU2161651C2 (sh)
SK (1) SK281878B6 (sh)
UA (1) UA35639C2 (sh)
WO (1) WO1996015247A1 (sh)
YU (1) YU71195A (sh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6153201A (en) * 1993-03-09 2000-11-28 University Of Rochester Oral immunization with papillomavirus virus-like particles
CA2200582C (en) * 1994-09-22 2007-03-27 Merck & Co., Inc. Dna encoding human papillomavirus type 6a
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
DK0973546T3 (da) * 1997-04-08 2004-06-28 Merck & Co Inc Stabiliserede formuleringer med human papillomavirus
KR20010072470A (ko) * 1998-08-14 2001-07-31 폴락 돈나 엘. 사람 유두종바이러스 바이러스-유사 입자의 정제방법
AUPP765398A0 (en) * 1998-12-11 1999-01-14 University Of Queensland, The Treatment of papillomavirus infections
PT1150712E (pt) 1999-02-05 2008-12-22 Merck & Co Inc Formulações para a vacina do vírus do papiloma humano
GB0206360D0 (en) 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
ATE427990T1 (de) 2002-04-30 2009-04-15 Oncolytics Biotech Inc Verbesserte reinigungsmethode fur viren
MY140664A (en) * 2003-09-29 2010-01-15 Merck Sharp & Dohme Optimized expression of hpv 45 l1 in yeast
US7901921B2 (en) 2004-10-22 2011-03-08 Oncolytics Biotech Inc. Viral purification methods
KR20170001720A (ko) 2007-03-14 2017-01-04 다케다 백신즈 인코포레이티드 바이러스 유사 입자 정제
MX2011013566A (es) * 2009-06-19 2012-06-28 Eyegene Inc Vacunas para cancer cervical.
JOP20130186B1 (ar) 2012-06-22 2021-08-17 Takeda Vaccines Montana Inc تنقية الجزيئات الشبيهة بالفيروسات
CN103936840B (zh) * 2013-01-18 2019-04-09 北京康乐卫士生物技术股份有限公司 重组的人乳头瘤病毒33型l1蛋白及其用途
CN113278064B (zh) * 2021-07-20 2021-11-02 山东信得科技股份有限公司 一种用于胚毒类抗原净化处理的方法及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122007000023I1 (de) * 1991-07-19 2007-08-09 Univ Queensland St Lucia Impfsstoff gegen Humanes Papillomavirus (typ 18)
US5437951A (en) * 1992-09-03 1995-08-01 The United States Of America As Represented By The Department Of Health And Human Services Self-assembling recombinant papillomavirus capsid proteins
DE122007000090I1 (de) * 1993-03-09 2008-03-27 Univ Rochester Herstellung von menschlichem papillomavirus hüllprotein und virus-ähnlichen teilchen
ATE328068T1 (de) * 1994-05-16 2006-06-15 Merck & Co Inc Papillomavirus vakzine

Also Published As

Publication number Publication date
CZ145297A3 (en) 1997-10-15
DK0789767T3 (da) 2003-10-20
DE69531308T2 (de) 2004-04-15
NZ298224A (en) 1999-05-28
SK281878B6 (sk) 2001-08-06
SK59497A3 (en) 1998-03-04
CN1173203A (zh) 1998-02-11
UA35639C2 (uk) 2001-04-16
HUT77559A (hu) 1998-06-29
AU708737B2 (en) 1999-08-12
RU2161651C2 (ru) 2001-01-10
AU4365896A (en) 1996-06-06
EP0789767B1 (en) 2003-07-16
AR004464A1 (es) 1998-12-16
DE69531308D1 (de) 2003-08-21
ES2201129T3 (es) 2004-03-16
WO1996015247A1 (en) 1996-05-23
BR9510520A (pt) 1998-07-14
MX9703570A (es) 1997-08-30
HRP950557A2 (en) 1997-08-31
JPH11500002A (ja) 1999-01-06
FI972030A0 (fi) 1997-05-13
EP0789767A1 (en) 1997-08-20
ATE245192T1 (de) 2003-08-15
PT789767E (pt) 2003-11-28
KR987000420A (ko) 1998-03-30
FI972030A (fi) 1997-05-13

Similar Documents

Publication Publication Date Title
YU71195A (sh) Prečišćeni proteini papilomavirusa
PT757717E (pt) Vacinas de papilomavirus
EP1916304A3 (fr) Polypeptides antigéniques associés à la sclérose en plaques et utilisations
AU4639396A (en) Cytokine designated lerk-7
MX9708678A (es) Proteasa activa, soluble del virus de la hepatitis c.
WO1996022308A3 (en) Appetite suppression factor and related methods
EP1359156A3 (en) Papilloma virus vaccine
AU2722997A (en) Influenza virus replicated in mammalian cell culture and vaccine production
ATE341627T1 (de) Als lerk6 bezeichnetes cytokin
CA2171699A1 (en) Expression of porcine reproductive respiratory syndrome virus polypeptides in the same cell
HUP0104794A2 (hu) Eljárás vírusrészecskék elkülönítésére
AU2212088A (en) Method for culturing recombinant cells
PT789766E (pt) Particulas quimericas do tipo papilomavirus
DE69425906T2 (de) Interleukin-15
AU1958092A (en) Recombinant fowlpox virus
EP1696035A3 (en) Improved bacillus host cell
AU3107699A (en) Novel forms of t cell costimulatory proteins, nucleic acid molecules, and uses thereof
ATE346498T1 (de) Als lerk6 bezeichnetes cytokin
GB2353531A (en) Conditional mutants of influenza virus M2 protein
WO2000018803A3 (en) Antibodies to mammalian langerhans cell antigen and their uses
AU4365196A (en) Purified genes encoding mammalian cell surface antigens; proteins and antibodies
CA2274474A1 (en) Synthetic hpv16 virus-like particles
WO2004024938A3 (en) Β1,4-n-acetylgalactosaminyltransferases, nucleic acids and methods of use thereof
DE60129607D1 (en) Dna-fpr-expression von alpha-i-antitrypsin in methylotropher hefe
DE69434135D1 (de) Rekombinante dnase b aus streptococcus pyogenes